Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy

Simona Di Giambenedetto, Roberto Cauda, Andrea De Luca, Angela Marzocchetti, Massimiliano Fabbiani, Laura Bracciale, M Nasi, A Cozzi Lepri, M Pinti, C Mussini, A. Cossarizza

Risultato della ricerca: Contributo in rivistaArticolo in rivista

24 Citazioni (Scopus)

Abstract

We investigated the rates of lipodystrophy events, according to mitochondrial DNA haplogroup, in 187 patients starting combination antiretroviral therapy and following it. Incidence rates of lipoatrophy and fat accumulation were 8.2 and 4.8 per 100 person-years of follow-up, respectively. In multivariable models, patients with haplogroup K were at higher risk of any lipodystrophy [adjusted relative risk (aRR) 4.02, P = 0.0009], lipoatrophy (competing-risk aRR 2.42, P = 0.09; cause-specific aRR 2.99, P = 0.031), and fat accumulation (competing-risk aRR, 2.63, P = 0.11; cause-specific aRR 5.27, P = 0.019) than those with haplogroup H. Mitochondrial haplogroups may explain part of the genetic predisposition to lipodystrophy during combination antiretroviral therapy.
Lingua originaleEnglish
pagine (da-a)113-120
Numero di pagine8
RivistaJournal of Acquired Immune Deficiency Syndromes
Volume59
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • Adult
  • Anti-HIV Agents
  • Antiretroviral Therapy, Highly Active
  • DNA, Mitochondrial
  • Female
  • Genetic Predisposition to Disease
  • HIV-1
  • HIV-Associated Lipodystrophy Syndrome
  • Haplotypes
  • Humans
  • Incidence
  • Italy
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Risk Factors

Fingerprint Entra nei temi di ricerca di 'Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy'. Insieme formano una fingerprint unica.

Cita questo